Best of ASCO 2024: What Patients Need to Know

Numerous significant updates were presented at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting, with the potential to impact the treatment landscape and improve outcomes for patients. In this live panel discussion, Oncology Data Advisor Editorial Board members Dr. Matthew Hadfield, Dr. Samuel Kareff, Dr. Morana Vojnic, and Dr. Nagashree Seetharamu share some of the most noteworthy updates that patients with cancer should know, including advances in melanoma, lung cancer, head and neck cancer, brain cancer, central nervous system (CNS) metastases, and more. Additionally, they answer audience questions and share their opinions about the data to help put these exciting advances into context.  

About the Speakers

Matthew Hadfield, DO, is a Medical Oncologist at Brown University/Legorreta Cancer Center, with a pending faculty appointment at the Warren Alpert School of Medicine of Brown University. He recently completed his Hematology/Oncology Fellowship at Brown University. Dr. Hadfield’s clinical and research interests are in phase 1 clinical trials and developmental therapeutics, as well as cutaneous malignancies and immunotherapy-related adverse events.

Samuel Kareff, MD, MPH, is a Medical Oncologist and the Outgoing Chief Hematology-Oncology Fellow at the University of Miami’s Sylvester Comprehensive Cancer Center and Jackson Memorial Hospital in Florida. He is soon to enter hybrid practice focusing on thoracic and gastrointestinal cancers. Dr. Kareff has special research interests in health advocacy, public policy, and the development of cancer therapies.

Morana Vojnic, MD, MBA, is an Assistant Professor of Medicine in the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Health and a Medical Oncologist at Lenox Hill Hospital, where she serves as Director of Oncologic Services in the Brain and Spine Metastases Program. She specializes in thoracic and neuro-oncology, with expertise in the treatment of lung cancer, mediastinal tumors, head and neck cancer, brain cancer, and metastatic lesions of the brain and spine. With a background in molecular genetics, Dr. Vojnic designs personalized treatment plans and protocols using targeted drugs, immunotherapy, and chemotherapy for the treatment of patients with these diseases.

Nagashree Seetharamu, MD, is a Professor in the Department of Medicine, Division of Hematology and Oncology, at the Barbara and Donald Zucker School of Medicine at Hofstra/Northwell Health. In addition to being a nationally and internationally renowned thoracic and head and neck oncologist, with a busy clinical practice, she is a very active academician. She has conducted several research projects in the fields of lung cancer prevention, early detection, predicative and prognostic biomarkers, as well as novel therapeutics in thoracic and head and neck oncology. In addition, Dr. Seetharamu is passionate about mentoring the new generation of oncologists and plays an active role in the fellowship program at Northwell Health. She also serves as a mentor for trainees in other institutions through the ASCO mentorship program.

Related Articles

Responses

Your email address will not be published. Required fields are marked *